Detalhe da pesquisa
1.
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546696
2.
Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper.
Br J Haematol
; 202(4): 734-744, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587091
3.
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.
Br J Haematol
; 201(4): 682-689, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822820
4.
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Br J Haematol
; 201(2): 267-279, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541152
5.
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
PLoS Med
; 18(1): e1003454, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428632
6.
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Br J Haematol
; 192(5): 853-868, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656799
7.
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Haematologica
; 106(7): 1957-1967, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499244
8.
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet Oncol
; 20(12): 1760-1772, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668592
9.
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(1): 57-73, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559051
10.
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies.
Antibodies (Basel)
; 13(1)2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534209
11.
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.
Cancers (Basel)
; 15(13)2023 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444449
12.
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.
Leukemia
; 35(7): 2043-2053, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262523
13.
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Lancet Haematol
; 6(12): e616-e629, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624047
14.
Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection.
Ann Hematol
; 88(11): 1155-6, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19399500
15.
Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.
J Clin Oncol
; 27(5): 763-9, 2009 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19124804
16.
Examination of the bone marrow.
Br J Hosp Med (Lond)
; 69(8): M124-7, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18783097